Clinical Trial Update: Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing leukocyte-rich PRP to leukocyte-poor PRP for knee cartilage degeneration in osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Leukocyte-rich PRP (platelet-rich plasma with leukocytes)
• leukocyte-poor PRP

Snippet

Sponsor: Istituto Ortopedico Rizzoli | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED